A Few of the Common Myths About Gene Therapy Include...
Gene Therapy is Withdrawing Substantial Public Funds from Conventional Research
A simple calculation shows that less than 1% of the public research funds are currently put into this field in our country and less than 2 % in the US. The reason is simple: most of the financial effort in the field of gene therapy is done by private investment
Gene Therapy Has Not Yet Proven Its Effectiveness
Gene therapy studies including improving heart defects, ADL, ADA, PNP, and other deficiencies, cancer, nicotine addiction, and many many other cases are full of proof and efficacy of the treatment of gene therapy.
Please refer to the link below, on the success stories of gene therapy:
Please refer to the link below, on the success stories of gene therapy:
Gene Therapy Will Be Invariably Expensive
The example of DNA-based vaccination should be sufficient to illustrate that gene based interventions can become much less expensive than conventional therapies if properly designed.
Gene Therapy has the Potential of Actively Interfering With Hereditary
Currently, interventions on the germ line are rightly forbidden in many countries, including our own, and this is fully justified by the current inability of our gene transfer protocols to drive the trans-gene to a precise chromosomal position. Also, only germ line therapy has the potential of altering the gene pool, however, germ line therapy has not been undergone in humans due to ethical questions, hence why somatic cell therapy is the more prevalent protocol. Finally, scientists do not have the potential of altering the gene pool for their own advantage simply because they do not have the power of eliminating mutations.
